Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 14, 2008
Feasibility of the sentinel node biopsy in anal cancerM Mistrangelo, M Bellò, A Mobiglia, et al.
Cancer Treatment Reviews|April 2, 2021
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trialsE F Giunta, G Bregni, A Pretta, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 12, 2015
Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?F Giunta, M Zotta, M Menga, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 18, 2019
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpressionS Napolitano, N Matrone, A L Muddassir, et al.
Reviews on Recent Clinical Trials|June 30, 2020
Light Alcohol Drinking and the Risk of Cancer Development: A Controversial RelationshipGiuseppe G Caprio, Desiree Picascia, Marcello Dallio, et al.
Minerva Anestesiologica|May 21, 2011
Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT)P Piccinni, D N Cruz, S Gramaticopolo, et al.
Italian Journal of Dermatology and Venereology|November 28, 2023
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitorsMatelda Medri, Francesco Savoia, Flavia Foca, et al.
Minerva Urology and Nephrology|December 13, 2022
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA ScoreGiuseppe Fornarini, Sara E Rebuzzi, Sebastiano Buti, et al.
Pageof 6